13F filerCIK 1536411 ↗

Duquesne Family Office

You are looking at Q2 2018. See the latest, Q3 2026 →

Reported value

$2.07B

+14% on the quarter before

Positions

33

19 new, 8 sold out

Top 10

76.9%

of the value

Est. gain

+$130.9M

on stocks held all quarter

Est. return

+10.9%

on those stocks since Q1 2018

Filed

Aug 14, 2018

On SEC EDGAR ↗

Positions as of Jun 30, 2018, from Duquesne Family Office's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

Each tile is a position, sized by its share, colored by what the fund did with it since Q1 2018. Striped tiles are options.

Microsoft14%Amazon13%Salesforce11%Alphabet9.3%Meta8.6%Alibaba7.2%
9 others4.3%
Gilead Sciences Inc4.1%
Workday3.8%Netflix3.6%
Vaneck Vectors ETF Tr2.1%
Stamps Com Inc1.9%
Marathon Pete Corp1.7%
Splunk Inc1.6%
Autodesk1.6%
Devon Energy Corp New1.6%
Adobe1.4%
Activision Blizzard Inc1.2%
Tal Ed Group1.2%
Select Sector SPDR Tr1.2%
Home Depot Inc1.2%
Ac Immune Sa1.1%
Clovis Oncology Inc1.1%
Ishares Tr1.0%
Ctrip Com Intl Ltd1.0%

Largest buys

Since Q1 2018, sized at quarter-end prices.

  1. Meta~$178.4MNew, 0.0% → 8.6% of the portfolio+918,000 shares
  2. Gilead Sciences Inc~$85.4MNew, 0.0% → 4.1% of the portfolio+1,205,300 shares
  3. Microsoft~$54.9MAdded, 12.3% → 14.2% of the portfolio+556,600 shares
  4. Vaneck Vectors ETF Tr~$44.1MNew, 0.0% → 2.1% of the portfolio+1,680,200 shares
  5. Marathon Pete Corp~$34.8MNew, 0.0% → 1.7% of the portfolio+496,400 shares
  6. Splunk Inc~$34.0MNew, 0.0% → 1.6% of the portfolio+342,600 shares
  7. Autodesk~$33.3MNew, 0.0% → 1.6% of the portfolio+254,300 shares
  8. Devon Energy Corp New~$32.6MNew, 0.0% → 1.6% of the portfolio+740,700 shares
  9. Alibaba~$27.3MAdded, 6.7% → 7.2% of the portfolio+146,900 shares
  10. Activision Blizzard Inc~$25.7MNew, 0.0% → 1.2% of the portfolio+337,200 shares

Largest sells

Since Q1 2018, sized at quarter-end prices.

  1. Intel~$128.3MSold out, 7.1% → 0.0% of the portfolio−2,462,600 shares
  2. Nektar Therapeutics~$126.7MSold out, 7.0% → 0.0% of the portfolio−1,192,300 shares
  3. Micron~$114.1MSold out, 6.3% → 0.0% of the portfolio−2,187,500 shares
  4. Alphabet~$100.2MCut, 14.9% → 9.3% of the portfolio−88,750 shares
  5. Jd Com Inc~$72.2MSold out, 4.0% → 0.0% of the portfolio−1,783,000 shares
  6. Amazon~$26.5MCut, 13.7% → 12.7% of the portfolio−15,600 shares
  7. Qualcomm~$22.8MSold out, 1.3% → 0.0% of the portfolio−411,000 shares
  8. Yandex N V~$12.0MSold out, 0.7% → 0.0% of the portfolio−304,000 shares
  9. Vipshop Hldgs Ltd~$9.5MSold out, 0.5% → 0.0% of the portfolio−572,800 shares
  10. Sterling Bancorp Del~$9.1MSold out, 0.5% → 0.0% of the portfolio−401,600 shares

Holdings

As of Jun 30, 2018; changes in shares since Mar 31, 2018.

Positions, sorted by share of the portfolio
HoldingValue
MicrosoftCOM · shares +23% · price +8.0%14.2%$294.5M+$17.8M
AmazonCOM · shares −9.1% · price +17.4%12.7%$263.9M+$39.2M
SalesforceCOM · shares 0% · price +17.3%11.2%$232.6M+$34.3M
AlphabetCAP STK CL A · shares −34% · price +8.9%9.3%$192.4M+$15.7M
MetaCL A · shares New8.6%$178.4M—
AlibabaSPONSORED ADS · shares +22% · price +1.1%7.2%$149.2M+$1.3M
Gilead Sciences IncCOM · shares New4.1%$85.4M—
WorkdayCL A · shares +14% · price −4.7%3.8%$78.8M−$3.4M
NetflixCOM · shares 0% · price +32.5%3.6%$74.3M+$18.2M
Vaneck Vectors ETF TrOIL SVCS ETF · shares New2.1%$44.1M—
Stamps Com IncCOM NEW · shares −2.2% · price +25.9%1.9%$39.1M+$8.0M
Marathon Pete CorpCOM · shares New1.7%$34.8M—
Splunk IncCOM · shares New1.6%$34.0M—
AutodeskCOM · shares New1.6%$33.3M—
Devon Energy Corp NewCOM · shares New1.6%$32.6M—
AdobeCOM · shares 0% · price +12.8%1.4%$29.9M+$3.4M
Activision Blizzard IncCOM · shares New1.2%$25.7M—
Tal Ed GroupSPONSORED ADS · shares 0% · price −0.8%1.2%$25.1M−$197,000
Select Sector SPDR TrENERGY · shares New1.2%$24.7M—
Home Depot IncCOM · shares New1.2%$24.7M—
Ac Immune SaSHS · shares 0% · price −9.9%1.1%$22.3M−$2.4M
Clovis Oncology IncCOM · shares New1.1%$21.9M—
Ishares TrNASDAQ BIOTECH · shares New0.98%$20.3M—
Ctrip Com Intl LtdAMERICAN DEP SHS · shares +38% · price +2.2%0.97%$20.1M+$308,496
BlockCL A · shares New0.73%$15.2M—
Total 33 positions100%$2.07B+$130.9M

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q1 2018 to Q2 2018: 14 stocks held throughout, up $130.9M (+10.9%).

  1. Amazon+$39.2M+17%
  2. Salesforce+$34.3M+17%
  3. Netflix+$18.2M+33%
  4. Microsoft+$17.8M+8%
  5. Alphabet+$15.7M+9%
  6. Tal Ed Group−$197,000−1%
  7. Pagseguro Digital Ltd Com−$369,791−28%
  8. Intra Cellular Therapies Inc−$1.0M−16%
  9. Ac Immune Sa−$2.4M−10%
  10. Workday−$3.4M−5%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

Pick a quarter to see what the fund held then.

$6.00B$3.00B$0
Q1 2016Q3 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q3 2026$4.47B−14%SEC ↗
Q2 2026$5.21B+54%SEC ↗
Q1 2026$3.38B−25%SEC ↗
Q4 2025$4.49B+11%SEC ↗
Q3 2025$4.06B−0%SEC ↗
Q2 2025$4.07B+33%SEC ↗
Q1 2025$3.06B−18%SEC ↗
Q4 2024$3.72B+26%SEC ↗
Q3 2024$2.95B+1%SEC ↗
Q2 2024$2.92B−34%SEC ↗
Q1 2024$4.39B+31%SEC ↗
Q4 2023$3.35B+20%SEC ↗
Q3 2023$2.79B−3%SEC ↗
Q2 2023$2.87B+25%SEC ↗
Q1 2023$2.31B+14%SEC ↗
Q4 2022$2.02B+15%SEC ↗
Q3 2022$1.76B+28%SEC ↗
Q2 2022$1.38B−40%SEC ↗
Q1 2022$2.31B−16%SEC ↗
Q4 2021$2.76B−10%SEC ↗
Q3 2021$3.08B−24%SEC ↗
Q2 2021$4.04B−11%SEC ↗
Q1 2021$4.53B+22%SEC ↗
Q4 2020$3.71B+8%SEC ↗
Q3 2020$3.44B+5%SEC ↗
Q2 2020$3.27B+32%SEC ↗
Q1 2020$2.47B−28%SEC ↗
Q4 2019$3.41B+33%SEC ↗
Q3 2019$2.57B−24%SEC ↗
Q2 2019$3.37B−2%SEC ↗
Q1 2019$3.45B+100%SEC ↗
Q4 2018$1.73B−18%SEC ↗
Q3 2018$2.10B+2%SEC ↗
Q2 2018$2.07B+14%SEC ↗
Q1 2018$1.81B−9%SEC ↗
Q4 2017$1.98B−10%SEC ↗
Q3 2017$2.20B+18%SEC ↗
Q2 2017$1.87B+22%SEC ↗
Q1 2017$1.52B+49%SEC ↗
Q4 2016$1.03B−9%SEC ↗
Q3 2016$1.13B+30%SEC ↗
Q2 2016$870.7M−35%SEC ↗
Q1 2016$1.34BSEC ↗

Subscribe to TheInference for free